Current state of the art in redox-sensitive polysaccharide-based prodrug scaffolds for improving therapeutic outcomes.
1/5 보강
With an immense advancement in the therapeutic technologies, redox-responsive drug delivery systems have been extensively explored preclinically for the treatment of several critical diseases, includi
APA
Abbasi YF, Wu L, et al. (2026). Current state of the art in redox-sensitive polysaccharide-based prodrug scaffolds for improving therapeutic outcomes.. Carbohydrate polymers, 373, 124654. https://doi.org/10.1016/j.carbpol.2025.124654
MLA
Abbasi YF, et al.. "Current state of the art in redox-sensitive polysaccharide-based prodrug scaffolds for improving therapeutic outcomes.." Carbohydrate polymers, vol. 373, 2026, pp. 124654.
PMID
41320413 ↗
Abstract 한글 요약
With an immense advancement in the therapeutic technologies, redox-responsive drug delivery systems have been extensively explored preclinically for the treatment of several critical diseases, including cancer. Particularly, considerable attention has been paid for the fabrication of polysaccharide-based prodrug scaffolds, where a variety of redox-responsive functional groups or pendants is employed to chemically conjugate small-molecule drugs with different carbohydrate polymers. The redox-responsive bonds of such scaffolds could be cleavable at the microenvironmental elevated glutathione (GSH) and reactive oxygen species (ROS) concentrations, triggering a rapid molecular conformational change and release of the bioactive cargos at the targeted sites and eventually minimize the systemic toxic effects. The present article provides an insight into the rational design and fabrication of recently developed redox-responsive polysaccharide-based prodrug scaffolds and their improved bio-performances relative to their therapeutic precursors, following a comprehensive overview on microenvironmental dysregulated redox homeostasis and various redox-responsive motifs. The prospects and challenges of these conjugates are also briefly discussed for future development of promising redox-responsive nanomedicines.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.